The International Imaging Registry in Liver Cirrhosis (BAVENO-VI SPSS GROUP).

NCT02692430 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2017-07-31

No results posted yet for this study

Summary

The purpose of this study is to perform a multicentre registry of cirrhotic patients who had been submitted to an imagining technique in recent years (angio-CT scan or abdominal MRI), in order to collect anatomical and clinical information. The main objective will be focused on the study of portosystemic shunts and their relation with portal hypertension.

Patient with liver cirrhosis submitted to an abdominal angio-CT scan or a MRI from year 2010 to 2014 will be included in the study. The chosen imaging technique will be angio-CT preferably, but MRI data will also be available. Patients will be identified in every hospital by means of the registry of coded diagnoses and the lists of complementary tests performed. Clinical and radiological data of every patient will be collected. The clinical variables will be obtained from reviewing the patient clinical history. The radiological parameters will be gathered by means of the systematic review of the angio-CT or MRI.

Conditions

Interventions

OTHER

No intervention is studied

Sponsors & Collaborators

  • IRCCS Policlinico S. Donato

    collaborator OTHER
  • Martin-Luther-Universität Halle-Wittenberg

    collaborator OTHER
  • Hospital Clinic of Barcelona

    collaborator OTHER
  • Hospital General Universitario Gregorio Marañon

    collaborator OTHER
  • Hospital Universitario Ramon y Cajal

    collaborator OTHER
  • Odense University Hospital

    collaborator OTHER
  • Puerta de Hierro University Hospital

    collaborator OTHER
  • Royal Free Hospital NHS Foundation Trust

    collaborator OTHER
  • University of Alberta

    collaborator OTHER
  • University Hospital, Bonn

    collaborator OTHER
  • University Hospital, Gasthuisberg

    collaborator OTHER
  • Vienna General Hospital

    collaborator OTHER
  • Hospital Universitari Vall d'Hebron Research Institute

    lead OTHER

Principal Investigators

  • Joan Genesca, MD · Vall d´Hebron Research Institut. Hospital Vall d´Hebron. Barcelona, Spain.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2017-10-31
Completion
2017-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02692430 on ClinicalTrials.gov